RENO, NV, UNITED STATES, April 9, 2025 /⁨EINPresswire.com⁩/ -- Sarcomatrix Therapeutics, a privately held biopharmaceutical company advancing transformative therapies for severe muscle diseases, today announced the renewal of its Orphan Drug Designation ( …